WHO Expert Committee on drug dependence.
D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use; D013759:Dronabinol / Q000009:adverse effects / Q000627:therapeutic use; D004335:Drug and Narcotic Control; D006801:Humans; D007391:International Cooperation; D011437:Propylamines / Q000009:adverse effects / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000627:therapeutic use; D019966:Substance-Related Disorders / Q000517:prevention & control*; D014944:World Health Organization
D011437:Propylamines; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D013759:Dronabinol